352 related articles for article (PubMed ID: 7991922)
1. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
[TBL] [Abstract][Full Text] [Related]
2. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue AS
Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
[TBL] [Abstract][Full Text] [Related]
3. [Additive effects of milrinone and dobutamine in severe heart failure].
Meissner A; Herrmann G; Gerdesmeyer L; Simon R
Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
[TBL] [Abstract][Full Text] [Related]
4. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
6. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
Pomer S; Elert O; Sarai K; Satter P
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
[TBL] [Abstract][Full Text] [Related]
9. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
Meissner A; Schmelzle T; Simon R
Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
12. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
Varriale P; Ramaprasad S
Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F
Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
[TBL] [Abstract][Full Text] [Related]
14. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
15. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.
Feneck RO; Sherry KM; Withington PS; Oduro-Dominah A;
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):306-15. PubMed ID: 11426360
[TBL] [Abstract][Full Text] [Related]
17. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
18. Milrinone in the treatment of low output states following cardiac surgery.
Wright EM; Skoyles J; Sherry KM
Eur J Anaesthesiol Suppl; 1992; 5():21-6. PubMed ID: 1600964
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study].
Dubois-Randé JL; Guérot C; Jan F; Brochier M; Sacrez A; Vacheron A; Bory M; Lambert H; Pony JC; Le Bloc'h Y
Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318
[TBL] [Abstract][Full Text] [Related]
20. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
